US OptionsDetailed Quotes

PLTR241213C62000

Watchlist

12.90
+1.95+17.81%

15min DelayClose Dec 13 16:00 ET

13.00High10.50Low

Palantir Stock Discussion

10xStockPicks

3 minutes ago

Buying This Takeover Target Offers 10X Upside. Esperion Therapeutics.

$Esperion Therapeutics (ESPR.US)$ $Esperion Therapeutics (ESPR.US)$ Esperion Therapeutics (ESPR) is a biotech company that focuses on developing and commercializing therapies to lower cholesterol, specifically offering the only FDA-approved statin alternatives: NEXLIZET and NEXLETOL for PRIMARY PREVENTION. These drugs are designed for individuals who are statin intolerant or cannot achieve adequate cholesterol lowering with statin...

PLTR only

3 hours ago

Monday will be exciting

$Palantir (PLTR.US)$

Monsoir Francois

6 hours ago

From $70k loss to $160k profits: My 2024 Stock Market Journey

In my previous post, I showed my 2024 P/L – seemed all roses right? Wrong, it’s actually been a mega roller coaster. I’ve been actively investing for over 3 years, starting with a small capital with the occasional DCA. Since I started when the markets were going down in 2022, I am usually more pessimistic in nature. But this year truly took the cake in testing my conviction, both in myself and the companies I bought shares in.
Startin...

2024 recap: Relive your key investment moments

STOCKS

$Palantir (PLTR.US)$ anyone can advise still worth it to invest palantir in short term or long term? as the price too high, scare buy now Wil drop...

103662178

18 hours ago

$Palantir (PLTR.US)$ What we should focus on next week is US Rate Cut. Nasdaq 100 inclusion announcement is already a past tense.

10xStockPicks

18 hours ago

This $2.25 Stock Soon To Turn A Profit Is Highly Likely To Be Acquired Above $10

This unique biotech $Esperion Therapeutics (ESPR.US)$ Esperion has the only FDA approved statin alternative drugs NEXLIZET & NEXLETOL for Primary Prevention, Statins are a class of prescription drugs that help lower cholesterol levels. They are the most common treatment for high cholesterol, an estimated 21 Million Americans are Statin intolerant and or maxed out on Statin drugs and need additional lowering. Over 71 ...